Using non-randomized trials to assess the clinical benefit of systemic anti-cancer treatments: Viable or not?

Xander NSH, Leeneman B, Dingemans AC, Fiets WE, de Jong WK, Uyl NEM, Wymenga ANM, Reyners AKL, Uyl-de Groot CA.

DOI: 10.1016/j.ejca.2024.114262
Published: 2024-08-03
Container: Eur J Cancer
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejca.2024.114262,
  title = {Using non-randomized trials to assess the clinical benefit of systemic anti-cancer treatments: Viable or not?},
  author = {Xander NSH and  Leeneman B and  Dingemans AC and  Fiets WE and  de Jong WK and  Uyl NEM and  Wymenga ANM and  Reyners AKL and  Uyl-de Groot CA.},
  year = {2024},
  journal = {Eur J Cancer},
  doi = {10.1016/j.ejca.2024.114262},
  url = {https://doi.org/10.1016/j.ejca.2024.114262}
}

RIS

TY  - JOUR
TI  - Using non-randomized trials to assess the clinical benefit of systemic anti-cancer treatments: Viable or not?
AU  - Xander NSH
AU  -  Leeneman B
AU  -  Dingemans AC
AU  -  Fiets WE
AU  -  de Jong WK
AU  -  Uyl NEM
AU  -  Wymenga ANM
AU  -  Reyners AKL
AU  -  Uyl-de Groot CA.
PY  - 2024
JO  - Eur J Cancer
DO  - 10.1016/j.ejca.2024.114262
UR  - https://doi.org/10.1016/j.ejca.2024.114262
ER  -

APA

NSH, X., B, L., AC, D., WE, F., WK, D. J., NEM, U., ANM, W., AKL, R., & CA., U. G. (2024). Using non-randomized trials to assess the clinical benefit of systemic anti-cancer treatments: Viable or not?. Eur J Cancer. https://doi.org/10.1016/j.ejca.2024.114262

Source records

europe-pmc · retrieved 2026-09-27T01:16:02.344Z